rdf:type |
|
lifeskim:mentions |
umls-concept:C0003015,
umls-concept:C0030705,
umls-concept:C0042402,
umls-concept:C0079284,
umls-concept:C0264716,
umls-concept:C0332206,
umls-concept:C0332293,
umls-concept:C0597357,
umls-concept:C1280500,
umls-concept:C1414262,
umls-concept:C1524081,
umls-concept:C1720127,
umls-concept:C2348358,
umls-concept:C2745878
|
pubmed:issue |
9
|
pubmed:dateCreated |
1996-12-6
|
pubmed:abstractText |
The importance of endothelin-1 in chronic heart failure (CHF) is unclear. We therefore investigated the effects of endothelin-converting enzyme (ECE) inhibition and endothelin ETA receptor blockade in CHF patients treated with ACE inhibitors. We also compared the function of ETA and ETB receptors in healthy subjects and patients with CHF.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin-Converting Enzyme...,
http://linkedlifedata.com/resource/pubmed/chemical/Aspartic Acid Endopeptidases,
http://linkedlifedata.com/resource/pubmed/chemical/Endothelin-1,
http://linkedlifedata.com/resource/pubmed/chemical/Glycopeptides,
http://linkedlifedata.com/resource/pubmed/chemical/Metalloendopeptidases,
http://linkedlifedata.com/resource/pubmed/chemical/Neprilysin,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides, Cyclic,
http://linkedlifedata.com/resource/pubmed/chemical/Protease Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Endothelin A,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Endothelin B,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Endothelin,
http://linkedlifedata.com/resource/pubmed/chemical/Vasoconstrictor Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Viper Venoms,
http://linkedlifedata.com/resource/pubmed/chemical/cyclo(Trp-Asp-Pro-Val-Leu),
http://linkedlifedata.com/resource/pubmed/chemical/endothelin-converting enzyme,
http://linkedlifedata.com/resource/pubmed/chemical/phosphoramidon,
http://linkedlifedata.com/resource/pubmed/chemical/sarafotoxins s6
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0009-7322
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
94
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2131-7
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:8901663-Aged,
pubmed-meshheading:8901663-Analysis of Variance,
pubmed-meshheading:8901663-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:8901663-Aspartic Acid Endopeptidases,
pubmed-meshheading:8901663-Brachial Artery,
pubmed-meshheading:8901663-Chronic Disease,
pubmed-meshheading:8901663-Endothelin-1,
pubmed-meshheading:8901663-Female,
pubmed-meshheading:8901663-Glycopeptides,
pubmed-meshheading:8901663-Heart Failure,
pubmed-meshheading:8901663-Humans,
pubmed-meshheading:8901663-Male,
pubmed-meshheading:8901663-Metalloendopeptidases,
pubmed-meshheading:8901663-Middle Aged,
pubmed-meshheading:8901663-Neprilysin,
pubmed-meshheading:8901663-Peptides, Cyclic,
pubmed-meshheading:8901663-Protease Inhibitors,
pubmed-meshheading:8901663-Receptor, Endothelin A,
pubmed-meshheading:8901663-Receptor, Endothelin B,
pubmed-meshheading:8901663-Receptors, Endothelin,
pubmed-meshheading:8901663-Regional Blood Flow,
pubmed-meshheading:8901663-Vasoconstriction,
pubmed-meshheading:8901663-Vasoconstrictor Agents,
pubmed-meshheading:8901663-Vasodilation,
pubmed-meshheading:8901663-Viper Venoms
|
pubmed:year |
1996
|
pubmed:articleTitle |
Vasodilator effects of endothelin-converting enzyme inhibition and endothelin ETA receptor blockade in chronic heart failure patients treated with ACE inhibitors.
|
pubmed:affiliation |
Medical Research Council Clinical Research Initiative in Heart Failure, University of Glasgow, Scotland, UK. m.love@biomed.gla.ac.uk
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Research Support, Non-U.S. Gov't
|